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SUMMARY: 
 
Canonical Wnt signaling coordinates many critical aspects of embryonic development, 
while dysregulated Wnt signaling contributes to common diseases, including congenital 
malformations and cancer. The nuclear localization of β-catenin is the defining step in 
pathway activation. However, despite intensive investigation, the mechanisms 
regulating β-catenin nuclear transport remain undefined. In a patient with congenital 
heart disease and heterotaxy, a disorder of left-right patterning, we previously identified 
the guanine nucleotide exchange factor, RAPGEF5. Here, we demonstrate that 
RAPGEF5 regulates left-right patterning via Wnt signaling. In particular, RAPGEF5, 
regulates the nuclear translocation of β-catenin independently of both β-catenin 
cytoplasmic stabilization and the importin β1/Ran mediated transport system.  We 
propose a model whereby RAPGEF5 activates the nuclear GTPases, Rap1a/b, to 
facilitate the nuclear transport of β-catenin, defining a parallel nuclear transport pathway 
to Ran. Our results suggest new targets for modulating Wnt signaling in disease states. 
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INTRODUCTION: 
Canonical Wnt signaling is a highly conserved regulatory pathway for many aspects of 
embryonic development and adult tissue homeostasis. When dysregulated, Wnt 
signaling contributes to numerous diseases, including congenital malformations, 
neurodegeneration, diabetes, and multiple cancers (Clevers and Nusse, 2012; 
MacDonald et al., 2009; Moon et al., 2004; Niehrs, 2012).  In the defining step of the 
pathway, nuclear translocation of β-catenin is essential. In fact, Wnt ligand binding 
inhibits the cytoplasmic β-catenin destruction machinery allowing β-catenin to 
accumulate and enter into the nucleus (MacDonald et al., 2009; Niehrs, 2012).  
However, despite intensive investigation, the regulators of β-catenin nuclear 
transport have been enigmatic. β-catenin lacks a nuclear localization signal (NLS) and 
does not require the Ran-GTPase-regulated importin/karyopherin transport carriers to 
access the nuclear compartment (Fagotto, 2013; Fagotto et al., 1998; Wiechens and 
Fagotto, 2001; Xu and Massague, 2004; Yokoya et al., 1999). Nevertheless, there are 
clear parallels with the Ran based system: 1) translocation of β-catenin occurs through 
Nuclear Pore Complexes (NPCs), 2) the armadillo (ARM) repeats in β-catenin are 
structurally similar to the ARM and HEAT repeats found in importin-α and importin-β 
family members, and β-catenin competes for NPC-binding sites with importin-β1, 3) 
nuclear import is energy dependent, and 4) import of β-catenin is inhibited by 
nonhydrolyzable GTP analogs, suggesting the involvement of an unknown GTPase 
(Fagotto, 2013; Fagotto et al., 1998; Jamieson et al., 2014; Lowe et al., 2015; Xu and 
Massague, 2004). Together, these data demonstrate that β-catenin uses a non-classic 
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pathway for nuclear transport; however, the molecular regulators of this process are 
unknown.  
We previously identified the guanine nucleotide exchange factor, RAPGEF5 as a 
candidate disease gene in a patient with congenital heart disease and heterotaxy 
(Fakhro et al., 2011). Heterotaxy is a disorder of left-right (LR) patterning. Normally, our 
internal organs, such as the heart, are asymmetrically positioned across the LR axis, 
and patients with heterotaxy can have an especially severe form of congenital heart 
disease (Brueckner, 2007; Sutherland and Ware, 2009). However, no developmental 
function for RAPGEF5 had been established. Here we show that RAPGEF5, regulates 
left-right patterning via Wnt signaling. Importantly, RAPGEF5 is critical for the nuclear 
localization of β-catenin independently of cytoplasmic stabilization and the importin α/β1 
mediated transport system. We propose a model whereby RAPGEF5 activates nuclear 
Raps to facilitate the nuclear transport of β-catenin, identifying new targets for 
modulating Wnt signaling in disease.  
 
RESULTS: 
Rapgef5 is required for left – right development 
To investigate whether RAPGEF5 is required for normal left-right development, we first 
examined organ situs in Rapgef5 depleted Xenopus embryos. The frog model, 
Xenopus, is ideal for these studies as both gain and loss of function experiments are 
rapid and efficient; for example, three days after manipulating fertilized Xenopus eggs, 
we can readily assess cardiac situs by simple inspection of Xenopus tadpoles (Blum et 
al., 2009). In vertebrates, the developing cardiac tube initially forms in the midline and 
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then normally loops to the right (D-loop). However, defects in left-right patterning result 
in morphological abnormalities, including leftward (L) or ambiguous (A) loops 
(Brueckner, 2007; Sutherland and Ware, 2009). Knockdown of rapgef5 using translation 
(R5 MOATG) or splice (R5 MOSplice) blocking morpholino oligonucleotides (MOs), as well 
as CRISPR mediated F0 depletion (Bhattacharya et al., 2015), resulted in abnormal 
cardiac looping and confirmed a role for Rapgef5 in left-right development (Fig. 1A, Fig. 
S1A). 
Left-right symmetry is first broken at the left-right organizer (LRO). Here motile 
cilia generate a leftward fluid flow that is detected by laterally positioned immotile 
sensory cilia and translated into asymmetric gene expression (Boskovski et al., 2013; 
Kennedy et al., 2007; McGrath et al., 2003; Tabin and Vogan, 2003; Yoshiba and 
Hamada, 2014). In particular, leftward flow results in the asymmetric expression of coco 
(dand5, cerl2) in the LRO, and subsequent activation of TGF-β family members and 
pitx2c expression in the left lateral plate mesoderm (Kawasumi et al., 2011; Logan et 
al., 1998; Schweickert et al., 2010; Vonica and Brivanlou, 2007). Knockdown of 
Rapgef5 resulted in abnormalities in both pitx2c and coco expression demonstrating 
that rapgef5 is required at the level of the LRO (Fig. 1B-C). To test the efficacy and 
specificity of our Rapgef5 depletion strategies, we employed multiple tests including 1) 
RT-PCR, 2) western blot, 3) control MO and CRISPR injection, and 4) rescue with 
human RAPGEF5 mRNA (Fig. 1B, Fig. S1, Fig. S2A). 
Importantly in the LRO, coco expression is normally symmetric prior to cilia 
driven flow (Schweickert et al., 2010) (Fig. 1C, far left panel, Stage (st) 16); however, in 
morphants coco expression was reduced even at these pre-flow stages (st 16, Fig. 1C), 
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suggesting a defect in the establishment of the LRO itself. This was confirmed by 
assaying expression of additional LRO marker genes, xnr1 and gdf3 (Hanafusa et al., 
2000; Lustig et al., 1996; Sampath et al., 1997; Vonica and Brivanlou, 2007), both of 
which were reduced before initiation of flow in morphants (Fig. 1D). Thus, Rapgef5 is 
required for correct establishment of the LRO and subsequent LR development. 
 
Depletion of Rapgef5 impairs canonical Wnt signaling 
As the LRO fails to form normally in rapgef5 morphants, we next examined the 
preceding development of this structure. Spemann’s organizer forms at the dorsal 
blastopore lip and serves to pattern dorsal structures, including the LRO (De Robertis et 
al., 2000; Harland and Gerhart, 1997; Khokha et al., 2005; Niehrs, 2004). There, we 
discovered that foxj1 and xnr3 transcripts, known direct targets of Wnt signaling (Caron 
et al., 2012; McKendry et al., 1997; Smith et al., 1995; Stubbs et al., 2008; Walentek et 
al., 2012), were reduced in gastrulating rapgef5 morphants (Fig. 2A). On the other hand, 
numerous additional dorsal, ventral, and pan-mesodermal markers appear unaffected or 
only mildly affected compared to the changes seen in foxj1 and xnr3 (Fig. S3A). We 
note that our Rapgef5 depletion becomes marked only after stage 10, when many of 
these mesodermal markers are already established (Fig. S2B). Again, injection of a 
control morpholino or control CRISPR had no effect on foxj1 expression, while injection 
of human RAPGEF5 mRNA rescued the foxj1 patterning defect in rapgef5 morphants, 
demonstrating the specificity of our knockdown strategies (Fig. S3B,C). Based on the 
reduction of foxj1 and xnr3 expression in rapgef5 morphants, we hypothesized that 
Rapgef5 may play a role in Wnt signaling. 
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Wnt signaling plays diverse roles in embryonic development, including formation 
of primary axes, as well as in common human diseases such as cancer (Clevers and 
Nusse, 2012; Jamieson et al., 2014; MacDonald et al., 2009; Moon et al., 2004; Niehrs, 
2012; Yamaguchi, 2001). β-catenin plays a central role in the canonical Wnt pathway 
(Fagotto et al., 1997; Funayama et al., 1995; Heasman et al., 1994; McCrea et al., 
1993). In the absence of Wnt ligand, cytoplasmic β-catenin is phosphorylated and 
marked for degradation by a highly efficient destruction complex consisting of GSK3, 
CK1, APC and Axin (Clevers and Nusse, 2012; Davidson et al., 2005; Kofron et al., 
2007; Liu et al., 2002; MacDonald et al., 2009; Niehrs, 2012; Taelman et al., 2010; Yost 
et al., 1996). This destruction complex maintains cytoplasmic β-catenin at low levels so 
that it cannot accumulate in the nucleus, repressing canonical Wnt signaling (Fig. 2B). 
When the Wnt ligand binds to the Frizzled receptor and the LRP6 co-receptor, the 
destruction complex is inactivated, and β-catenin accumulates and translocates into the 
nucleus to induce transcription of Wnt target genes (Bhanot et al., 1996; Davidson et al., 
2005; Fagotto et al., 1997; Funayama et al., 1995; He et al., 1997; Heasman et al., 
1994; MacDonald et al., 2009; Mao et al., 2001a; Mao et al., 2001b; Niehrs, 2012; 
Pinson et al., 2000; Tamai et al., 2000; Yang-Snyder et al., 1996) (Fig. 2B). Therefore, 
we began our analysis of the Wnt pathway by examining β-catenin protein levels from 
whole embryo lysates in rapgef5 morphants. By western blot, β-catenin protein levels 
were reduced in rapgef5 morphants at stages 10 and 12 compared to uninjected 
controls (Fig. 2C,D). Conversely, β-catenin levels were increased by overexpression of 
human RAPGEF5 (Fig. 2D). Importantly, while levels of total β-catenin were mildly 
affected, the active (unphosphorylated) pool of β-catenin that translocates into the 
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nucleus was much more severely affected (Fig. 2C,D). Together these observations 
lead us to postulate that Rapgef5 may be required for the cytoplasmic stabilization of β-
catenin. 
 
Rapgef5 acts downstream of cytoplasmic stabilization 
To test whether Rapgef5 functions in cytoplasmic stabilization, we first asked if Rapgef5 
depletion could counteract the activity of wild type (WT) and stabilized (ST) β-catenin 
proteins. The degradation machinery phosphorylates β-catenin at specific 
serine/threonine residues via GSK3; modification of these residues to alanine (S33A, 
S37A, T41A) prevents phosphorylation and produces a “stabilized” form of β-catenin 
that evades the degradation machinery (Liu et al., 2002; Taelman et al., 2010; Yost et 
al., 1996). Overexpression of β-catenin can induce a second embryonic axis in Xenopus 
embryos (Funayama et al., 1995; Guger and Gumbiner, 1995), which can be easily 
scored by simple inspection (Fig. 3A, left panel). Co-injection of either rapgef5 MO or 
GSK3 mRNA significantly reduces the ability of WT β-catenin mRNA to induce 
secondary axes in Xenopus embryos (Fig. 3A), suggesting that Rapgef5 acts at the 
level of β-catenin signaling rather than upstream in the pathway. As expected, co-
injection of GSK3 mRNA has no effect on the ability of stabilized β-catenin to induce a 
secondary axis. However, surprisingly, co-injection of rapgef5 MO did reduce the ability 
of stabilized β-catenin to induce secondary axes (Fig. 3A) suggesting that Rapgef5 acts 
independently of β-catenin stabilization. 
An alternative method to assay Wnt signaling, TOPFlash luciferase assays place 
luciferase expression under the control of TCF/LEF binding sites (Molenaar et al., 1996; 
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van de Wetering et al., 1997; van de Wetering et al., 1991; Veeman et al., 2003). In this 
case, activation of Wnt signaling leads to the accumulation of nuclear β-catenin that 
complexes with TCF/LEF to activate luciferase expression. Consistent with our induced 
secondary axis experiments, Rapgef5 depletion reduced the luciferase signal of both 
WT and stabilized β-catenin in TOPFlash assays in Xenopus embryos (Fig. 3B). To see 
if this result was conserved to mammals, we depleted Rapgef5 using siRNAs in primary 
mouse embryonic fibroblasts. In mice, the specific serine/threonine residues that are 
phosphorylated by GSK-3 and lead to degradation of β-catenin are encoded on a single 
exon. Excision of this exon creates cells that express a genetically stabilized β-catenin 
allele (Harada et al., 1999). Even in cells with the stabilized β-catenin allele, depletion of 
Rapgef5 led to decreased luciferase activity (Fig. 3C).  
To further test whether Rapgef5 regulates Wnt signaling independently of β-
catenin degradation, we pursued a parallel strategy to inhibit GSK3 activity 
pharmacologically using the chemical inhibitor BIO (Sato et al., 2004). Wnt signaling 
must be attenuated to form the head (Glinka et al., 1998; Yamaguchi, 2001), so 
activation of Wnt signaling with BIO between stages 9 and 12 leads to a dramatic 
reduction in head development. Knockdown of rapgef5 using either R5 MOATG or R5 
MOSplice counteracted the effect of BIO and rescued development of the head (Fig. 3D). 
Taken together, these studies in both frogs and mammals indicate that Rapgef5 
regulates Wnt signaling independently of the well-established β-catenin cytoplasmic 
destruction machinery, suggesting that Rapgef5 acts downstream in the Wnt signaling 
pathway (Fig. 2B). 
 
	 10	
Nuclear translocation of β-catenin is impaired in rapgef5 morphants 
Our initial experiments with whole embryo lysates indicated that β-catenin levels were 
lower with Rapgef5 depletion (Fig. 2C,D); therefore, we had initially hypothesized that 
Rapgef5 plays a role in β-catenin degradation. Given the results described above, we 
sought alternative explanations and began with studies to examine β-catenin 
localization. To directly visualize β-catenin, we injected GFP tagged WT and stabilized 
β-catenin mRNA at the one cell stage and imaged the dorsal blastopore lip at stage 10. 
Concurrently, to enable ratiometric analysis with an importin-β1 transported cargo, we 
co-injected mCherry tagged with a N-terminal classic nuclear localization signal from 
SV40 large T antigen (“PKKKRKV”; NLS-mCherry). In control embryos, the GFP tagged 
β-catenin localized robustly to dorsal nuclei and the plasma membrane; however, levels 
of nuclear β-catenin were significantly diminished in rapgef5 morphants whether we 
used the WT or stabilized variant of β-catenin. We examined this result in two ways. 
First, we compared GFP and RFP signals in the cytoplasm compared to the nucleus. In 
both WT β-catenin-GFP and stabilized β-catenin-GFP injected embryos, the 
nuclear:cytoplasmic ratio of β-catenin was reduced with depletion of Rapgef5 while no 
effect was observed with the NLS-mCherry (Fig. 4A,B far right panels). Second, we 
compared the nuclear signal from β-catenin (green channel) to nuclear signal of NLS-
mCherry (red) and observed a reduction in the β-catenin-GFP/mCherry ratio in Rapgef5 
depleted embryos (Fig. 4A,B middle panels). As a control, we examined the levels of β-
catenin (both nascent and GFP tagged forms) by Western blot, demonstrating that 
Rapgef5 depletion had no significant effect on levels of injected GFP-b-catenin (Fig. 
S4).  
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We noted in these experiments that our NLS-mCherry faithfully localizes to the 
nucleus even when β-catenin nuclear localization is impaired due to Rapgef5 depletion. 
We wondered if adding the NLS signal from SV40 to β-catenin might “rescue” the 
nuclear localization phenotype in embryos depleted of Rapgef5. In both the secondary 
axis assay (Fig. 3A) and the visualization of GFP signal (Fig. 4C), addition of a classic 
NLS signal to β-catenin makes it insensitive to Rapgef5 depletion. Furthermore, in 
rapgef5 morphants, co-injection of NLS-β-catenin rescued expression of the Wnt target 
gene foxj1 and LR patterning (pitx2c) (Fig. 5A,B). Taken together, depletion of Rapgef5 
has little effect on the Ran/importin-β1 nuclear transport pathway, which can rescue β-
catenin nuclear translocation and LR development upon the addition of a classic NLS-
signal. Therefore, Rapgef5 may define a parallel nuclear transport system that is critical 
for β-catenin. 
We next sought to evaluate the endogenous levels of β-catenin in different 
cellular compartments. We fractionated the nucleus and cytoplasm and examined the 
levels of β-catenin by Western blot (Fig. 6). In wild type Xenopus embryos at stage 10, 
β-catenin is present in both nuclear and the cytoplasmic/plasma membrane fractions 
(where it plays a critical role in cell adhesion (Brembeck et al., 2006) (Fig. 6A). In 
rapgef5 morphants, levels of β-catenin were significantly reduced in the nucleus despite 
a relatively minor reduction in the cytoplasm (Fig. 6A,C). If we treat the embryos with 
the GSK-3 inhibitor, BIO, and normalize the intensities of β-catenin to control embryos 
without BIO treatment, inhibition of the degradation machinery increases the amount of 
β-catenin in both the cytoplasmic and nuclear fractions (Fig. 6B,C). However, when we 
deplete Rapgef5, the amount of β-catenin in the nucleus is substantially reduced 
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despite there being more cytoplasmic β-catenin than in wildtype embryos (Fig. 6C). 
From these studies, we conclude that rapgef5 depletion inhibits the nuclear localization 
of β-catenin even if the cytoplasmic levels of endogenous β-catenin are high due to 
inhibition of the cytoplasmic destruction machinery. 
 
A Rapgef5 centered nuclear translocation system 
If rapgef5 regulates nuclear translocation of β-catenin, then its expression and activity 
must be consistent with a role at this location. We first examined its developmental 
expression pattern and subcellular localization. Using anti-sense mRNA in situ 
hybridization, we find that both Rapgef5 and paralogs of its target GTPases, Rap1 and 
Rap2 (Quilliam et al., 2002; Rebhun et al., 2000), are expressed in multiple tissues 
throughout development, including the blastopore lip and LRO (Fig. S5). By 
immunohistochemistry, Rapgef5 protein is localized specifically to the nuclei of both 
whole mount and paraffin sectioned wild type Xenopus embryos at stages 10 and 28 
(Fig. S6A) and was reduced in rapgef5 morphants (Fig. S6A panel 2,3). Rapgef5 is also 
localized specifically to the nuclei of human RPE cells and mouse embryonic fibroblasts 
suggesting an evolutionary conserved nuclear function (Fig. S6B,C). Consistent with 
previously documented roles in cell adhesion and migration (Caron, 2003), the isoforms 
of Rapgef5’s target Rap proteins localize near the plasma membrane as well as in the 
cytoplasm based on immunofluorescence or expression of fluorescently tagged proteins 
(Fig. S6D). Intriguingly, Rap1B, Rap2A and Rap2B also localize to the nucleus, while 
Rap1A accumulated in a reticular pattern that encompasses the perinuclear region 
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suggesting a distribution throughout the nuclear envelope and ER (Fig. S6D). These 
results suggest an evolutionary conserved nuclear RAP system. 
Based on their nuclear localization and previously reported biochemical activity 
(de Rooij et al., 2000; Quilliam et al., 2002; Rebhun et al., 2000), we propose a working 
model whereby Rapgef5 maintains nuclear Rap proteins in their active GTP bound 
state, which is crucial for the nuclear translocation of β-catenin (Fig. S7D). Indeed, 
previous reports have suggested that Rap1 localizes to the nucleus, influences nuclear 
β-catenin levels, and alters gene transcription profiles (Bivona and Philips, 2005; Goto 
et al., 2010; Lafuente et al., 2007). As a preliminary test of our model (Fig. S7D), we 
asked if nuclear Raps are in their active GTP bound conformation. GFP-RBDRalGDS is 
an active Rap sensor, consisting of the Ras binding domain of RalGDS fused to GFP, 
and binds specifically to the active form of Rap1-GTP and Rap2-GTP but not the 
inactive GDP form to allow visualization of subcellular localization (Bivona and Philips, 
2005; Liu et al., 2010). In addition to the previously described signals at the plasma 
membrane, we confirmed high levels of active Raps within Xenopus nuclei (Fig. 7A). 
Our model would also predict that active Raps and β-catenin physically interact. In 
support of this, we found that Rap1 co-immunoprecipitated with β-catenin, and 
importantly that β-catenin is pulled down specifically with RBDRalGDS, indicating that 
active Rap1/2 binds β-catenin in stage 10 Xenopus embryos (Fig. 7B,C), results 
consistent with a previous report in human cancer cell lines (Goto et al., 2010). We 
confirmed the specificity of RBDRalGDS for active GTP bound Raps by its selective 
ability to pull down a Rap1b mutant (G12V), that mimics the GTP bound form (CA – 
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constitutively active) but not a Rap1b mutant (S17N) which mimics the GDP bound form 
(DN – dominant negative) (Fig. S7A,B). 
 There are five Rap paralogs (Rap1a, Rap1b, Rap2a, Rap2b, Rap2c), and many 
of these proteins are localized to the nucleus (Fig. S6D). In order to identify a subset of 
Raps required in canonical Wnt signaling, we overexpressed constitutively active (CA, 
G12V) and dominant negative (DN, S17N) mutant forms of many of these Raps and 
examined β-catenin protein levels. In this context, total β-catenin levels were 
significantly reduced following over-expression of DN Rap1a or Rap1b mutants and 
increased when we expressed the CA forms (Fig. S7C). No significant difference was 
observed between Rap2a CA and DN injected embryos (Fig. S7C). RBDRalGDS readily 
bound the CA but not the DN form of Rap1b, confirming that the Rap mutants function 
as predicted (Fig. S7A). To determine whether Rap1 proteins mediate Rapgef5’s 
function in canonical Wnt signaling, we next over-expressed Rap1b DN and CA mRNAs 
in embryos depleted of Rapgef5 and assayed expression of the Wnt responsive gene, 
foxj1. Importantly, the CA form of Rap1b partially rescued the foxj1 phenotype of 
Rapgef5 morphants, while the DN form had no affect (Fig. 7D).  Taken together, we 
conclude 1) Rapgef5 and multiple Rap proteins localize to the nucleus, 2) at least a 
subset of the Raps in the nucleus are in the active GTP form, 3) active Rap proteins 
physically interact with β-catenin, 4) The GTP bound state of Rap1a and Rap1b 
differentially regulates both β-catenin levels and transcription of Wnt target genes 
downstream of Rapgef5. 
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DISCUSSION: 
Integrating the sum of our data, we develop a model where RAPGEF5 activates nuclear 
Raps, which are necessary for the translocation of β-catenin to the nucleus. This model 
parallels the classic Ran based transport system, which maintains a nuclear pool of 
Ran-GTP through the activity of a chromatin-bound Ran-GEF, RCC1 (Kutay et al., 
1997; Lange et al., 2007; Lowe et al., 2015; Xu and Massague, 2004). Structurally, β-
catenin’s 12 Arm repeats are similar to the HEAT repeats found on importin-β family 
members suggesting that it might directly interact with the FG-nups of the NPC central 
channel (Fagotto, 2013; Xu and Massague, 2004). Consistent with this idea, importin-β1 
can inhibit the translocation of β-catenin into the nucleus suggesting competition for 
NPC binding sites (Fagotto, 2013; Fagotto et al., 1998; Kutay et al., 1997; Xu and 
Massague, 2004). Finally, like the Ran based transport system, β-catenin’s nuclear 
translocation is energy dependent and depletion of ATP/GTP or addition of 
nonhydrolyzable GTP analogs (Fagotto et al., 1998) inhibits nuclear import, suggesting 
the involvement of a GTPase. 
However, β-catenin nuclear import is independent of the Ran based transport 
system, and the identity of the GTPase was unknown. We propose that the requirement 
of RAPGEF5 for β-catenin nuclear translocation implicates a Rap GTPase in this role 
(Fig. S7D). Supporting this idea is our observation that addition of a classic NLS signal 
to β-catenin decouples β-catenin import from Rapgef5 and allows it to use the 
importin/Ran system for nuclear translocation, rescuing both Wnt target gene 
expression (foxj1) and LR development (pitx2c) in rapgef5 morphants. Furthermore, 
active Raps are co-localized with Rapgef5 in the nucleus and are able to bind β-catenin. 
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Finally, overexpression of CA Rap1b can at least partially rescue the effect of Rapgef5 
depletion on Wnt target gene expression while DN Rap1b cannot. Our original 
observation was that β-catenin levels are reduced in total cell lysates from Rapgef5 
depleted embryos, suggesting a role in β-catenin stabilization. However, integrating the 
sum of our data, we conclude that Rapgef5 depletion partitions β-catenin out of the 
nucleus and into the cytoplasm where the degradation machinery is active. Of note, 
maternal stores of Rapgef5 protein prevent us from affecting β-catenin until the onset of 
gastrulation, so in contrast to the case when β-catenin is directly depleted (Heasman et 
al., 1994; Heasman et al., 2000; Khokha et al., 2005), expression of many Wnt 
responsive genes such as gsc and chordin are only minimally affected. Nevertheless, 
the Wnt responsive genes xnr3 and foxj1 are particularly sensitive and provided a 
critical clue to an affected pathway, although additional studies are necessary to 
evaluate other pathways as well. 
Elucidating the precise mechanism of β-catenin nuclear transport requires further 
study, and peculiar differences with the Ran based transport system, or roles for 
additional rap paralogs, may be discovered. For example, while Rapgef5 is the only 
Rapgef currently known to localize specifically to the nucleus, there are multiple 
Rapgefs and Rapgaps and further studies should examine whether these establish a 
differential in Rap GTPase activity similar to that observed in the Ran system. 
Importantly, while Rap2 paralogs also localize to the nucleus, overexpression of CA and 
DN Rap2a did not elicit an effect on β-catenin levels similar to that caused by injection 
of CA and DN Rap1. Rap2a has previously been implicated in the stabilization of β-
catenin at the level of the plasma membrane, and a stabilized β-catenin mutant 
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localized to the nucleus efficiently following Rap2 depletion, suggesting that Rap2 
paralogs may not play a critical role in the nuclear transport of β-catenin (Choi and Han, 
2005; Park et al., 2013). Importantly, how active Rap1 affects nuclear transport of β-
catenin is uncertain. One possibility is that Rap1-GTP differentially binds β-catenin 
compared to the Rap1-GDP form, or alternatively they bind equally, but Rap1-GTP is 
localized differentially in the nucleus. In addition, whether the binding between active 
Raps and β-catenin is direct or indirect warrants further investigation. 
Currently, whether Rapgef5 activity contributes to the import of β-catenin through 
NPCs or functions in a pathway that mediates β-catenin retention in the nucleus 
remains uncertain (Fig. 7D). Additionally, Ran-GTP acts to release 
karyopherin/importins from their NLS-bearing cargos; whether a β-catenin cargo is 
present or not remains to be seen. Importantly, Rapgef5 is localized to the nuclei of all 
examined cells in the embryo suggesting that its role in cell signaling is equally broad. 
Indeed, while our investigation has focused exclusively on Rapgef5’s function in 
canonical Wnt signaling, other pathways may also be affected. Further studies will need 
to address whether the function of Rapgef5 is restricted to β-catenin or if it also effects 
the nuclear localization of other Ran independent nuclear localizing proteins, such as 
APC, p120 catenin, and Smad2. 
We began our studies investigating a disease candidate gene identified in a patient 
with Heterotaxy and congenital heart disease. By using our high-throughput animal 
model, Xenopus, we identified an LR patterning defect in Rapgef5 depleted embryos, 
and given our desire to understand the pathophysiology of our patient, we discovered a 
role of Rapgef5 in the nuclear localization of β-catenin, an essential step in the Wnt 
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signaling pathway. Wnt signaling has a broad impact across embryonic development, 
stem cells, and multiple diseases. In particular, aberrant Wnt signaling and Rap activity 
are associated with numerous cancers. Of note, increased levels of nuclear Rapgef5 
have recently been linked with hereditary nonpolyposis colorectal cancer, a tumor with a 
well-established connection to the Wnt pathway (Chen et al., 2013). Thus, further 
exploration of Rapgef5 and its effectors may provide novel therapeutic targets and be of 
considerable relevance to human disease. 
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FIGURE LEGENDS: 
Figure 1. Rapgef5 depletion disrupts left-right development. (A) Percentage of 
Rapgef5 depleted embryos with abnormal cardiac looping (A or L loops). (B) Pitx2c is 
expressed in the left lateral mesoderm of stage 28 control Xenopus embryos (red arrow, 
lateral view anterior to the top), but is abnormally, typically bilaterally, expressed 
following MO or CRISPR mediated depletion of Rapgef5. Co-injection of human 
RAPGEF5 mRNA can rescue pitx2c in Rapgef5 morphants. (C) coco expression in the 
LRO of control and Rapgef5 depleted embryos at stages 16 and 19. Ventral view with 
anterior to the top. Graphs depict the percentage of embryos displaying abnormal coco 
expression. Note the reduced expression in rapgef5 morphants at both stages. (D) xnr1 
and gdf3 expression is reduced in the LRO of rapgef5 morphants at stage 16, prior to 
the onset of cilia driven flow. Ventral views with anterior to the top. A single asterisk 
indicates statistical significance of P<0.05, while double and triple asterisks indicate 
P<0.01 and P<0.005, respectively. Also see Figure S1 and Figure S2. 
Figure 2. Depletion of Rapgef5 impairs canonical Wnt signaling. (A) Depletion of 
Rapgef5 using MOs or CRISPR impairs foxj1 and xnr3 expression in the dorsal 
blastopore lip of stage 10 embryos. A; anterior, L; left, R; right, P; posterior. (B) 
Simplified schematic of the canonical Wnt signaling pathway. Left side: in the absence 
of Wnt ligand, a destruction complex containing Axin and Gsk3 phosphorylates β-
catenin, which marks it for cytoplasmic destruction. Right side: Once the pathway is 
activated by Wnt ligand binding to Frizzled and Lrp receptors, phosphorylation of β-
catenin by GSK3 is inhibited allowing β-catenin to accumulate in the cytoplasm and 
translocate into the nucleus to initiate transcription of Wnt target genes. (C, D) Levels of 
total and active β-catenin protein are essentially unchanged in Rapgef5 depleted 
embryos at stage 9 as assayed by western blot. However, both forms of β-catenin are 
reduced at stages 10 and 12. Note that levels of active β-catenin are much more 
severely affected. Conversely, overexpression of human RAPGEF5 mRNA results in a 
mild increase in total β-catenin levels and a more pronounced increase in active β-
catenin levels. Triple asterisks indicates P<0.005. Also see Figure S3. 
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Figure 3. Rapgef5 acts downstream of β-catenin cytoplasmic stabilization. (A) The 
ability to induce secondary axes in development can be used as a read out of Wnt 
signaling activity. Uninjected embryos have a single axis (dotted green line) while 
embryos injected with β-catenin mRNA can have a second embryonic axis (two dotted 
red lines) that are readily detected at st 16-19 embryos. Injection of WT, stabilized (ST), 
or NLS tagged β-catenin can induce secondary axes. Rapgef5 depletion significantly 
decreases the percentage of secondary axes induced by WT and ST β-catenin. 
Injection of GSK3 mRNA reduces secondary axes induced by WT β-catenin but has no 
effect on ST β-catenin. The ability of NLS-β-catenin to induce secondary axes is 
unaffected by reduction of Rapgef5 levels. (B) Rapgef5 knockdown reduces luciferase 
activity in embryos injected with WT or ST β-catenin mRNA in a TOPFlash assay. Data 
are represented as mean ± SD. (C) Wnt signaling activity is reduced in ST β-catenin 
MEFs (Dexon3) following siRNA depletion of Rapgef5. The schematic depicts the 
Catnblox(ex3) mouse allele. Exon 3 (E3), containing the GSK3 phosphorylation sites 
that target β-catenin for cytoplasmic degradation, is flanked by loxp sites allowing for its 
conditional removal and production of a stabilized (ST) β-catenin allele. WT: WT cells; 
FOP: ST β-catenin cells transfected with FOPFlash negative control; TOP: ST β-catenin 
cells transfected with TOPFlash reporter plasmid; TOP + R5 siRNA: ST β-catenin cells 
transfected with Rapgef5 siRNA and TOPFlash reporter plasmid; Top + C. siRNA: ST β-
catenin cells transfected with control siRNA and TOPFlash reporter plasmid. A Renilla 
luciferase transfection control was included in each treatment to allow normalization. 
Data are represented as mean ± SEM. (D) Pharmacological inhibition of GSK3 by the 
addition of BIO between stages 9 – 11 results in increased β-catenin signaling and loss 
of anterior development in Xenopus embryos. Depletion of Rapgef5 can counteract this 
effect and rescue development of the head demonstrating that Rapgef5 regulates Wnt 
signaling downstream of GSK3. A single asterisk indicates P<0.05, while double and 
triple asterisks indicate P<0.01 and P<0.005, respectively.  
Figure 4. Rapgef5 is required for the nuclear localization of β-catenin. (A,B) GFP 
tagged WT and ST β-catenin localize to the plasma membrane and nucleus in the 
dorsal blastopore lip of stage 10 control embryos but this nuclear localization is lost in 
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rapgef5 morphants (note loss of nuclear GFP signal in merged images). (C) NLS β-
catenin-GFP localizes normally into nuclei even in the absence of Rapgef5. Graphs in 
the center panel represent the ratio of nuclear localized GFP relative to nuclear 
localized NLS-Cherry control. Controls were normalized to ease comparison. The 
graphs on the right display ratiometric analysis of nuclear vs cytoplasmic GFP (β-
catenin) and NLS-mCherry levels. Nuclear localized β-catenin is reduced in Rapgef5 
morphants relative to controls for WT and stabilized β-catenin but not NLS-β-catenin. 
Localization of NLS-mCherry is unaltered. All data represented as mean ± SE. A double 
asterisk indicates P<0.01, a triple asterisk p<0.005.  
Figure 5. NLS β-catenin rescues foxj1 transcription and LR patterning defects in 
Rapgef5 morphants. Depletion of Rapgef5 reduces the expression of the Wnt 
responsive gene foxj1 and alters LR patterning (pitx2c). Co-injection of 50pg of NLS-β-
catenin mRNA significantly rescues (A) expression of foxj1 at stage 10 and (B) pitx2c 
expression in Rapgef5 depleted embryos. A single asterisk indicates P<0.05, a double 
asterisk P<0.01. 
Figure 6. Depletion of Rapgef5 impairs nuclear translocation of endogenous β-
catenin.  (A) Nuclear/cytoplasmic fractionation reveals that levels of endogenous β-
catenin are reduced in the nuclei of Rapgef5 morphants, while cytoplasmic levels are 
essentially normal. (B) BIO treatment does not rescue the nuclear localization of 
endogenous β-catenin. (C) Quantification of average β-catenin levels in nuclear and 
cytoplasmic fractions of control and morphant embryos with or without BIO treatment 
(error bars represent S.E.M.). All nuclear treatments (black bars) are relativized to the 
BIO untreated nuclear control and all cytoplasmic treatments (grey bars) are relativized 
to the BIO untreated cytoplasmic control. Note the reduction of nuclear localized β-
catenin in Rapgef5 depleted embryos with or without BIO treatment. The BIO treated 
rapgef5 morphants have less nuclear localized β-catenin than BIO untreated UC 
controls, despite having higher levels of cytoplasmic β-catenin. The cellular 
compartment markers (H3 for nuclear fraction and β-actin for cytoplasmic fraction) 
displayed in A and B are overexposed in order to demonstrate the degree of 
purification. For quantitation of β-catenin (C), shorter exposures of the gel (unsaturated) 
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were used in which these markers serve to normalize the amount of protein loaded for 
each compartment.  A single asterisk indicates P<0.05, a double asterisk P<0.01. 
Figure 7. Active Raps and β-catenin interact. (A) The GFP-RBDRalGDS active Rap 
sensor reveals the presence of active Raps in the nucleus and plasma membrane of 
dorsal blastopore lip cells at stage 10. (B) Rap1 protein co-immunoprecipitates with β-
catenin. (C) Immunoprecipitation of active Rap proteins from stage 10 Xenopus 
embryos using the RalGDS sensor. β-catenin immunoprecipitates with active Raps 
demonstrating an interaction, BC; β-catenin. (D) Injection of CA (constitutively active) 
Rap1b mRNA can partially rescue loss of foxj1 expression in rapgef5 morphants, while 
DN (dominant negative) Rap1b mRNA does not. A triple asterisk indicates P<0.0001. 
Also see Figure S7. 
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STAR METHODS: 
 
Contact for Reagent and Resource Sharing  
Further information and requests for reagents may be directed to, and will be fulfilled by 
the corresponding author Mustafa K. Khokha (mustafa.khokha@yale.edu) 
 
Experimental Model and Subject Details 
 
Xenopus 
X. tropicalis were maintained and cared for in our aquatics facility, in accordance with 
Yale University Institutional Animal Care and Use Committee protocols. Embryos were 
produced by in vitro fertilization and raised to appropriate stages in 1/9MR + gentamycin 
as per standard protocols (del Viso and Khokha, 2012).  
 
Mice 
Production of the mouse Catnblox(ex3) allele, carrying a loxP flanked β‐catenin exon 3, 
was as previously described (Harada et al., 1999). Heterozygous Catnblox(ex3) female 
mice were mated to a pCAGGCre-ERTM male (Hayashi and McMahon, 2002) to 
produce tamoxifen inducible pCAGG+/cre;Catnb+/lox(ex3) embryos. Murine embryonic 
fibroblasts (MEFs) were obtained by standard protocols. Briefly, the eviscerated trunk of 
E12.5 embryos was isolated, finely minced with a clean scalpel, trypsin and DNAse 
treated, and plated in MEF media. All mice were of mixed genetic background and 
housed in the New Hunt’s House Biological Services Unit at King’s College London and 
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all work was approved by the Ethical Review Board at King’s College London and 
performed in accordance with United Kingdom Home Office License 70/7441. 
 
Method Details 
Morpholino oligonucleotides, mRNA and CRISPRs 
Injections of Xenopus embryos were carried out at the one-cell stage using a fine glass 
needle and Picospritzer system, as previously described (Khokha et al., 2002). We 
obtained ATG blocking (R5 MOATG, 5’ –CTTTAAAAGTCTGACACCCATGAGC– 3’), 
splice blocking (R5 MOSplice, 5’ – GCCTAAGGAAAAACTCTTACCTCCA – 3’), and 
scrambled control morpholino oligonucleotides from Gene Tools LLC and injected 8ng 
at the one cell stage to deplete Rapgef5. CRISPR sgRNAs containing the following 
rapgef5 target sequences (5’ – GGACTTCCTTCTCACATACA - 3’) were designed from 
the v7.1 model of the Xenopus tropicalis genome. sgRNAs and Cas9 protein was used 
to genetically knockdown rapgef5 or tyrosinase in F0 embryos. Briefly stated, one cell 
embryos were injected with 1.5ng Cas9 Protein (PNA-Bio) and 400pg of targeting 
sgRNA and raised to desired stages as previously described in detail (Bhattacharya et 
al., 2015). Full length human RAPGEF5 (clone HsCD00511998) was subcloned into the 
pCSDest2 vector using Gateway recombination techniques. Capped mRNAs were 
generated in vitro by first linearizing using appropriate restriction enzymes and then 
transcribing with the mMessage machine kit (Ambion), following the manufacturer’s 
instructions. β-catenin-GFP (Addgene #16839) (Miller and Moon, 1997), Stabilized β-
catenin-GFP (Addgene #29684) (Taelman et al., 2010), NLS β-catenin-GFP (Addgene 
#16838) (Miller and Moon, 1997), NLS-mCherry (Addgene #49313) (Kirchmaier et al., 
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2013), TOPFlash (#12456) and FOPFlash (#12457) (Veeman et al., 2003) plasmids 
were obtained from Addgene. GFP-Rap1A, GFP-Rap1B, mCherry-Rap1B, GFP-XRap2, 
GFP-Rap2B and GFP-RBDRalGDS plasmids were generous gifts from Prof. Philip Stork 
at OHSU, Prof. Han at the Pohang University of Science and Technology, South Korea 
and Prof. Mark Philips at NYU. Constitutively active (G12V) and dominant negative 
(S17N) mutants for each Rap paralog were produced using the GeneArt strings DNA 
fragment service of Life Technologies and were subsequently cloned into pcDNA3. 
 
Cardiac Looping 
Stage 45 Xenopus embryos were paralyzed with benzocaine and scored with a light 
microscope. Looping was determined by position of the outflow tract. A D-loop was 
defined as the outflow tract going to the right, an L-loop was to the left, and an A-loop 
was midline.  
 
RT-PCR 
The R5 MOSplice morpholino was targeted to the splice donor site in intron 2 of rapgef5. 
Retention of intron 2 was confirmed by RT-PCR, using the following primers: Forward:5’ 
TCCACTGTACAAGTGAAGGAAGA 3’, reverse: 5’ TGTCTTGTACCTCATCCAGG 3’. 
 
In Situ Hybridization 
Digoxigenin-labeled antisense probes for chordin: Tneu011C22, coco: TEgg007d24, 
fgf8: Tneu007i10, foxj1: Tneu058M03, gdf3: Tgas137g21, gsc: TNeu077f20, noggin: 
TNeu122a14, not; TEgg044k18, otx2; TGas114a06, pitx2; TNeu083k20, Rap1A: 
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TEgg114f09, Rap2A: TGas143d22, Rap2B; TGas123a15, t; TGas116l23, rapgef5; 
IMAGE:6494175, vent; TNeu119b08, xnr1 TGas124h10, and xnr3; Tgas011k18 were in 
vitro transcribed with T7 High Yield RNA Synthesis Kit (E2040S) from New England 
Biolabs. Embryos were collected at the desired stages, fixed in MEMFA for 1–2 hours at 
room temperature and dehydrated into 100% ETOH. Briefly summarized, whole mount 
in situ hybridization of digoxigenin-labeled antisense probes was performed overnight, 
the labelled embryos were then washed, incubated with anti-digoxigenin-AP Fab 
fragments (Roche 11093274910), and signal was detected using BM-purple (Roche 
11442074001), as previously described in detail (Khokha et al., 2002).  
 
Immunofluorescence 
Xenopus embryos and mammalian cells were collected at desired time points and fixed 
in 4% paraformaldehyde/PBS (Xenopus = overnight (ON) at 4oC, cells = 15 mins at RT). 
Stage 10 Xenopus embryos were also embedded in paraffin and cut into 10 μm 
sections. Paraffin was removed using histoclear before beginning the IF. All samples 
were washed three times in PBS + 0.1% TritonX-100 before incubating in PBS + 0.1% 
Tween-20 + 3% BSA blocking solution for 1 hr at RT. Samples were then placed in 
blocking solution + primary antibody ON at 4oC. Samples were washed three times in 
PBS + 0.1% TritonX-100 before incubating in blocking solution + secondary antibody for 
2hrs at RT. Samples were washed three times in PBS + 0.1% Tween-20, one of which 
included a 5 min incubation in dapi (1:5000), and washed again. Anti-RAPGEF5 
(abcam, ab129008, 1:1000 dilution) was used as primary antibody. Alexa 488, 594, 647, 
and Texas red conjugated anti-mouse and rabbit secondary antibodies were obtained 
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from Thermo Fisher Scientific. Alexa647 phalloidin (Molecular Probes, 1:40) was also 
used to stain cell membranes in some cases.  Mammalian cells and Xenopus sections 
were mounted in Pro-Long Gold (Invitrogen) before imaging on a Zeiss 710 confocal 
microscope. 
 
Mammalian cell culture and siRNA knockdown of Rapgef5 
Mammalian embryonic fibroblasts (MEFs) were grown in DMEM supplemented with 
10% FBS, L-glutamine, Penicillin streptomycin, hepes and β-mercaptoethanol. To 
knockdown Rapgef5, cells were transfected with non-overlapping Rapgef5 siRNAs 
(Santa Cruz # sc-152703), or with control siRNA (Santa Cruz sc-36869) using 
lipofectamine RNAiMAX transfection reagent (Thermo Fisher Scientific #13778100) as 
per the manufacturer’s instructions. Cells were incubated with siRNA overnight in serum 
free medium before being returned to MEF media for 36 hours. 
 
TOPFlash Assays 
Xenopus embryos were injected with 200pg of GFP-WT-β‐catenin or GFP-Stabilized-β‐
catenin plasmids, along with 100pg of either the TOPFlash or FOPFlash (negative 
control) plasmids at the one cell stage. 20pg of Renilla plasmid was co-injected as an 
internal control. A subset of TOPFlash and β‐catenin injected embryos were also 
injected with either 8ng of the Rapgef5 splice morpholino or 200pg of Gsk3 mRNA. 
Pools of 10 embryos were collected and lysed in 100μl passive lysis buffer.  
In the mammalian cell culture experiments, Rapgef5 was depleted in 
pCAGG+/cre;Catnb+/lox(ex3) MEFs (carrying a tamoxifen inducible β‐catenin gain of 
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function allele) by siRNA knockdown. β‐catenin was stabilized by the tamoxifen induced 
deletion of exon 3 after 36 hours and cells were collected for analysis at 48hrs.  
Luciferase was quantified using the Dual Luciferase Reporter Assay System 
(Promega #E1910). Briefly, samples were lysed in 100ul of luciferase assay reagent 
and levels of TOPFlash driven firefly luciferase activity were measured using a Promega 
Glomax luminometer. 100ul of Stop & Glo reagent was then added to allow 
quantification of the Renilla luciferase control, as described in detail in the 
manufacturer’s instructions. Each experiment was carried out in technical and biological 
triplicate. 
 
Double axis assay and β‐catenin localization experiments 
For the secondary axis assay, embryos were injected at the one cell stage with 150pg 
of WT β‐catenin-GFP, Stabilized β‐catenin-GFP or NLS β‐catenin-GFP mRNAs. A 
subset of each group was then injected with either 8ng of the R5 MOATG morpholino or 
with full length GSK3 mRNA. Embryos were collected at stage 19 and scored for the 
presence of a secondary axis. To examine the subcellular localization of β‐catenin in 
Xenopus embryos, 150pg of WT β‐catenin-GFP, Stabilized β‐catenin-GFP or NLS β‐
catenin-GFP mRNAs were co-injected with NLS-cherry mRNA at the one cell stage. 
Samples were collected at stage 10 and fixed in 4% PFA overnight. The dorsal 
blastopore lip was dissected, mounted on coverslips in Pro-Long Gold (Invitrogen) and 
imaged with a Zeiss 710 confocal microscope. Image analysis was carried out using 
ImageJ. 
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Pharmacological inhibition of Gsk3 
To inhibit GSK3α/β function during anterior development in WT Xenopus embryos and 
morphants, 6-bromoindirubin-3′-oxime (BIO, Sigma-Aldrich B1686) was added to the 
media at a concentration of 10 μM between stages 8 and 11. Media was then changed 
and the embryos allowed to develop. Anterior development was scored as normal, 
reduced or absent as presented in Fig. 2. For the nuclear/cytoplasmic fractionation 
experiments BIO was added at stage 4 (1 μM concentration) and the embryos were 
collected at stage 10. 
 
Co-Immunoprecipitation and active Rap pulldown 
Pools of stage 10 Xenopus embryos were lysed in NP-40 buffer (150 mM NaCl, 1.0% 
NP-40, 50 mM Tris, pH 8.0, 10 μl/embryo) on ice. Samples were centrifuged for 10 mins 
at 13,000 rpm and the supernatant removed to a clean tube. Supernatant was then pre-
incubated with protein G beads (Bio-Rad, # 1614023) for 1 hour, centrifuged to collect 
supernatant, and incubated with primary antibody (Anti-β-catenin H-102, Santa Cruz, 
sc-7199) overnight. Protein G beads were then added to the sample solution and 
incubated for 3 hrs at 4oC. Lysate was centrifuged and the supernatant discarded. The 
beads were washed and centrifuged with 0.1% PBS-Tween six times. 2x SDS loading 
dye was added to the beads and heated to 95oC for five mins. The sample was 
centrifuged again and the lysate moved to a clean tube. For the active Rap1 and Rap2 
pull down experiments, lysate was incubated with GST-RalGDS-RBD fusion protein 
overnight at 4o C to allow binding, free protein was washed away, and active Rap1 and 
Rap2, as well as interacting proteins, were then eluted. The active rap detection kit (Cell 
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signaling Technologies #8818) was used as per the manufacturer’s instructions. 
Samples were analyzed by Western blot. 
Nuclear/cytoplasmic protein fractionation 
Pools of 30 embryos were collected at stage 10 for each treatment including controls in 
eppendorf tubes, (a maximium of 35 and minimum of 20 embryos can be used with the 
solution volumes outlined in this protocol, but the protein concentrations will vary). All 
centrifugation steps were done at 4oC. 1 ml of Buffer E1 (see below for details for E1, 
E2, E3) was added to the embryos, and they were homogenized using a pipette. 
Lysates were centrifuged at 13,000 rpm at 4oC for 5 min. Approximately 600-650 μl of 
the supernatant was transferred to a new eppendorf tube (avoiding the lipid fraction) 
and placed on ice (cytoplasmic fraction). The remaining supernatant was discarded, and 
any lipids were removed from the tube walls using a Kimwipe, talking care not to disturb 
the pellet (nuclear fraction).  
The nuclear and cytoplasmic fractions were then purified. For the cytoplasmic 
fraction, 11 μl of buffer CERII from the NE-PER Nuclear and Cytoplasmic Extraction 
Reagents Kit (Thermo-Scientific #78833) was added and tubes were vortexed for 15 
sec, incubated on ice for 5 min and centrifuged for another 5 min. The supernatant (~ 
500 μl) was transferred to a clean tube again avoiding lipid contamination. This 
cytoplasmic fraction was stored at -80oC until use. 
The nuclear fraction pellet was resuspended in 1 ml of buffer E1 by pipetting (some 
material might remain insoluble), incubating on ice for 5 min and centrifuging for 5 min. 
The supernatant was discarded following centrifugation and any lipids were removed 
using Kimwipes without touching the pellet. This washing step was then repeated. After 
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the second centrifugation the pellet was resuspended in 1 ml of buffer E2 and 
centrifuged for 5 min. The supernatant was discarded. This step was repeated once. 
Subsequently, the nuclear pellet was resuspended in 500 μl of buffer E3 and 
centrifuged for 5 min. The supernatant was discarded and the pellet was finally 
resuspended in 150 μl of Buffer E3. This is the nuclear fraction. 
In these experiments, the fractions come from the same number of cells - we lyse a 
defined set of Xenopus embryos, and then fractionate into nuclear and cytoplasmic 
ratios. Once these fractions are made, we load the same amount of protein per lane and 
verify by loading controls (actin - cytoplasm, histone - nuclear). Quantifications are 
normalized to the amounts of respective loading controls. The loading controls (histone 
and actin) displayed in Figure 6 are overexposed in order to demonstrate the degree of 
purification in the fractionation. For quantitation of β-catenin we used shorter 
(unsaturated) exposures.  Protein concentrations of the nuclear and cytoplasmic 
fractions were determined using DC Protein Assay (Biorad # 5000112). Protein fractions 
were stored at -80oC. All buffers were supplemented with proteinase inhibitor 
(Complete, Roche # 11697498001) and PMSF (0.2 mM final concentration) prior to use. 
Buffer E1 was also supplemented with DTT (1 mM final concentration). 
Buffer compositions: Buffer E1: 50 mM HEPES-KOH, 140 mM mL NaCl, 1 mM  
EDTA (pH 8.0), 10% Glycerol (v/v), 0.5% Igepal CA-630 (v/v), 0.25% Triton X-100 (v/v). 
Buffer E2: 10 mM Tris-HCl (pH 8.0), 200 mM NaCl, 1 mM EDTA (pH 8.0), 0.5 mM 
EGTA (pH 8.0). Buffer E3: 10 mM Tris-HCl (pH 8.0), 200 mM NaCl, 1 mM EDTA (pH 
8.0), 0.5 mM EGTA (pH 8.0), 1% (v/v) Sodium deoxycholate (from a 10% [w/v] solution), 
5% (v/v) Sodium N-lauroylsarcosine (from a 10% [w/v] solution). 
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Western blotting 
For total embryo western blots, pools of 10 control and treated embryos were collected 
at stage 9, 10 or 12 and placed in 100 ul of 1 x RIPA buffer. Embryos were then 
crushed using a pestle and spun down twice to separate lysate from lipids and debris. 
Embryos for nuclear and cytoplasmic analysis fractionations were isolated as described 
above. Western blotting was carried out following standard protocols and 45 μg of 
protein was loaded in each lane in 4-12% Tris-Bis gels. Anti-β-catenin (Santa Cruz sc-
7199, 1:1000 in 5% milk), anti-active-β-catenin (Millipore 05-665), anti-GAPDH (Ambion, 
AM4300 1:5000 dilution), anti-β-actin (cytoplasmic marker, santa cruz Sc-4778), anti-
Histone H3 (nuclear marker, Abcam, ab1791; 1:2000 dilution), anti-RAPGEF5 (abcam, 
ab129008, 1:200 dilution), anti-Rap1 (Enzo, ADI-KAP-GP125, 1:250) and anti-Rap2 
(Abcam #ab166785, 1:500) primary antibodies were used. Anti-mouse or anti-rabbit 
HRP conjugated secondary antibodies were used (Jackson Immuno Research 
Laboratories, 715–035–150 or 211–032–171 1:15000 dilution). Bands were quantified 
using ImageJ and relativized to controls. Injections and protein fractionations were 
repeated 3 times. The cellular compartment markers (H3 for nuclear fraction and β-actin 
for cytoplasmic fraction) displayed in Fig. 6A,B are overexposed in order to demonstrate 
the degree of purification. For quantitation of β-catenin (Fig. 6C), shorter exposures of 
the gel (unsaturated) were used in which these markers serve to normalize the amount 
of protein loaded for each compartment. Western blot images show representative 
results and graphs show the averages of the different replicates. 
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Quantification and Statistical Analysis 
For Xenopus experiments we estimated 20–25 samples per experimental condition 
were necessary for statistical significance given the magnitude of the changes 
expected. Typically, many more samples were obtained for each experiment except as 
noted in the figures. Statistical significance is reported in the figures and legends. In all 
figures, statistical significance was defined as P<0.05. In Figures 1, 2, 5, S1 and S3 the 
in situ results were analyzed by chi-squared test or Fishers exact test as appropriate for 
sample size. In Figure 3 the double axis assay data was examined using fishers exact 
test, the BIO treatment by Chi-squared and the TOPFlash by t-test. For Figure 4 a t-test 
(two-tailed, type two) was used to determine significance of the ratiometric analysis, and 
in Figure 6 the western blot data was analyzed by Anova Sidak.  
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Figure S1. Related to Fig. 1; Depletion of Rapgef5. (A) Knockdown of Rapgef5 
disrupts cardiac looping. Ventral views of Xenopus tadpoles with dorsal to the top. 
Representative examples of a normal (D-loop outlined in blue lower panel), and 
abnormal (A-Loop outlined in green, L-Loop outlined in red) looped heart. Injection of 
a control MO or a control CRISPR (targeting tyrosinase) does not affect cardiac 
looping. (B) Injection of a control MO or control CRISPR (targeting tyrosinase) does 
not cause abnormalities in pitx2c expression. (C) The control (tyrosinase) CRISPR 
reduces pigments levels in stage 45 Xenopus embryos, demonstrating that the control 
CRISPR/CAS9 system functions as expected. (D) Rationale of R5 MOSplice design. The 
splice MO targets the splice donor site at the start of intron 2. Failure to excise intron 
2 results in a premature stop codon early in the Rapgef5 protein. RT-PCR confirms 
that R5 MOSplice causes retention of intron 2. In genomic DNA, intron 2 spanning 
primers amplify a band of 547bp. In WT cDNA, these primers amplify a band of 157bp. 
PCR primers amplifying cDNA from R5 MOSplice morphants generate a band at 547bp 
indicating retention of intron 2 in mRNA. A “no template” negative control is also 
included. A single asterisk indicates P<0.05 and a triple asterisk P<0.005. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2, Griffin et al. 
 
 
Figure S2. Related to Fig. 1; Depletion of Rapgef5 protein. (A) Western blot 
demonstrating the efficacy of the R5 MOATG, R5 MOSplice, and CRISPR mediated 
Rapgef5 depletion in stage 10 Xenopus embryos. Overexpression of human 
RAPGEF5 mRNA increases protein levels. (B) Timeline of Rapgef5 depletion. Rapgef5 
protein levels were unaltered in morphants at late blastula stages (st 8 and 9) but 
reduced at stage 10 and 12. The graph represents fold changes in Rapgef5 protein 
levels in control and depleted embryos relative to the stage 8 uninjected controls. 
Figure S3, Griffin et al. 
 
 
 
Figure S3.  Related to Fig. 2; Expression of gastrulation genes in rapgef5 
morphants.  (A) At stage 10, expression of numerous gastrulation markers (gsc, 
chordin, fgf8, otx2, vent, t, not and noggin) are less affected by depletion of Rapgef5 
compared to foxj1 or xnr3 (See Fig. 2A). Vegetal views with dorsal to the top. (B) 
Injection of a control MO or a control CRISPR (targeting tyrosinase) does not affect 
foxj1 expression (C) Co-injection of human RAPGEF5 mRNA can rescue the loss of 
foxj1 expression in Rapgef5 morphants, demonstrating the specificity of the MO. Triple 
asterisks indicate P<0.005. 
 
Figure S4, Griffin et al. 
 
 
 
Figure S4. Related to Fig. 4 Translation of injected GFP tagged β-catenin mRNAs. 
Depletion of Rapgef5 by (A) ATG or (B) Splice MOs did not significantly affect 
translation of GFP tagged WT, ST, or NLS β-catenin mRNAs compared to controls. 
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Figure S5. Related to Fig. 6; Developmental expression of Rapgef5 and Rap 
genes. In situ hybridization reveals rapgef5 mRNA is present from the earliest stages 
of development. It is detected in the animal pole at the 2 cell and 8 cell stages. In the 
stage 10 embryos expression appears diffuse around the blastopore.  At stage 14 
transcripts are detected in the anterior neural folds and forming GRP. rapgef5 
expression is restricted to the anterior neural tube, brain, pharyngeal arches and 
cranial placodes at stage 28. Rap1A, Rap2A and Rap2B are all expressed in the 4 cell 
embryo, in the gastrulating stage 10 embryo and in the GRP at stage 16. Expression 
of all three genes is also strong in the neural folds at stage 16, while Rap2B also 
displays a speckled pattern on the lateral ectoderm. All three are expressed in the 
neural tube, brain, eye and pharyngeal arches at stage 28. 
Figure S6, Griffin et al. 
 
 
 
 
Figure S6. Related to Fig. 6; The subcellular localization of Rapgef5 and Rap 
proteins. (A1) Rapgef5 is localized to the nuclei in a section of a stage 10 Xenopus 
embryo. (A2 - 7) Rapgef5 is detected specifically in the nuclei of sectioned paraffin 
embedded stage 28 Xenopus embryos but is reduced in morphants (Compare A2 and 
A3, magenta Rapgef5, blue DAPI). The lines on the schematic in A4 represent the 
plane of section shown in A4 and A5. A6 and A7 are higher magnification of the white 
boxes in A4 and A5, respectively. (B, C) Rapgef5 localizes specifically to the nuclei of 
mouse MEFs and human RPE cells. (D) With the exception of Rap1A all rap proteins 
localize both to the plasma membrane and nucleus as assayed by injection of 
GFP/RFP tagged constructs or by immunofluorescence.  
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Figure S7. Related to Fig. 7; A Rap1 mediated transport system. (A) Validation of 
the CA (constitutively active) and DN (dominant negative) Rap1 constructs.  
RBDRalGDS selectively pulls down endogenous active RAPs, as well as the GFP 
tagged CA, but not the DN Rap1b mutant. (B) While the GFP tagged CA and DN Rap1 
constructs can be equally detected in the total lysate, the level of the CA form is greatly 
reduced in the first flow through from the pull down columns, reflecting the binding of 
CA Rap1 to RBDRalGDS and its retention in the column. (C) Injection of CA Rap1a or 
Rap1b leads to an increase in total β-catenin protein levels relative to controls, while 
injection of the DN forms causes a decrease in total β-catenin levels. Injection of Rap2a 
CA or DN did not reveal a differential effect on β-catenin. (D) Proposed model for 
Rapgef5s role in nuclear localization of β-catenin. Rapgef5 maintains nuclear Raps in 
their active GTP bound confirmation, which is required for 1) – the nuclear import of β-
catenin or 2) – retention of β-catenin within the nuclear compartment.  
 
